Queens Eye Center brings all technologies to bear on the treatment of posterior segment illness. The vitreous and retina provide challenges for which both diagnostic and therapeutic sophistication is required.

Photodynamic therapy for the treatment of "wet," age-related macular degeneration (ARMD) is performed, together with the use of the newest, anti-endothelial growth factors, (Macugen).

Onsite ophthalmic ultrasound is available for evaluation of retinal detachments, vitreous hemorrhage and retinal neoplasms, and fluorescein angiography allows evaluation of macular degeneration as well as diabetic and hypertensive retinopathy.